Alector (ALEC) Common Equity (2018 - 2026)
Alector (ALEC) posted quarterly Common Equity of $10.4 million for Q1 2026, down 89.03% year-over-year from $94.6 million in Q1 2025, and down 66.13% quarter-over-quarter from $30.6 million in Q4 2025.
Alector (ALEC) Common Equity (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Common Equity for 9 consecutive years, with $10.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 89.03% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 89.03% YoY), while the FY2025 annual figure was $30.6 million, down 75.83% from the prior year.
- Common Equity declined to $10.4 million in Q1 2026 per ALEC's latest filing, from $30.6 million in the prior quarter.
- Across five years, Common Equity topped out at $288.5 million in Q2 2022 and bottomed at $10.4 million in Q1 2026.
- Historically, Common Equity has averaged $149.4 million across 5 years, with a median of $150.6 million in 2024.
- Annual changes were most pronounced in 2022 — Common Equity surged 56.36% — and 2026, when it plunged 89.03%.
- Alector's Common Equity stood at $214.4 million in 2022, then tumbled by 37.44% to $134.2 million in 2023, then slipped by 5.48% to $126.8 million in 2024, then sank by 75.83% to $30.6 million in 2025, then sank by 66.13% to $10.4 million in 2026.
- Business Quant data shows ALEC's Common Equity at $10.4 million in Q1 2026, $30.6 million in Q4 2025, and $57.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -9.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.97 Mn |
| Mar 31, 2026 | 10.38 Mn |
| Dec 31, 2025 | 30.65 Mn |
| Sep 30, 2025 | 57.71 Mn |
| Jun 30, 2025 | 71.18 Mn |
| Mar 31, 2025 | 94.61 Mn |
| Dec 31, 2024 | 126.80 Mn |
| Sep 30, 2024 | 118.93 Mn |
| Jun 30, 2024 | 150.57 Mn |
| Mar 31, 2024 | 178.91 Mn |
| Dec 31, 2023 | 134.16 Mn |
| Sep 30, 2023 | 162.56 Mn |
| Jun 30, 2023 | 196.31 Mn |
| Mar 31, 2023 | 183.02 Mn |
| Dec 31, 2022 | 214.44 Mn |
| Sep 30, 2022 | 253.10 Mn |
| Jun 30, 2022 | 288.52 Mn |
| Mar 31, 2022 | 267.54 Mn |
| Dec 31, 2021 | 300.72 Mn |
| Sep 30, 2021 | 335.89 Mn |